OR WAIT null SECS
August 03, 2021
Acquisition of US partner establishes Sanofi's plan to advance messenger RNA technology for vaccines, therapeutics
July 30, 2021
Baltimore facility production was stopped after FDA flagged millions of contaminated doses
July 28, 2021
German drugmaker also plans to set up manufacturing facilities in Africa
July 27, 2021
Deal for antibody developer expected to be largest ever for scientific instrument maker
In-house center eliminates the need for a contract manufacturer, company says
July 23, 2021
How pharma’s retooling of its promotional efforts in the post-pandemic era impacts sizing and targeting, two crucial foundational pieces to successful commercialization
July 22, 2021
Per agreement, facility will be producing over 100 million doses annually for use in African Union
July 21, 2021
Robotic filling and capping equipment to be installed in NIBRT’s global bioprocessing training and research center
Plans a multi-phase, $100 million expansion, adding biologics drug substance manufacturing capabilities
July 20, 2021
Deal allows CDMO to quickly expand its drug delivery technologies in the US